In the breast cancer microenvironment, tumor-derived Transforming Growth Factor Beta (TGF-β) induces HDN-to-LDN conversion via the SMAD3 signaling pathway, while spontaneous HDN conversion in advanced-stage patients may be linked to mitochondrial dysfunction (31, 32). The gene discussed is TGFB1; the disease is breast carcinoma.